Cytek Biosciences Inc.

CTKB | NASDAQ

Price Alert Chart Builder DCF Calculator

$5.28

-$0.02 (-0.38%)

At close: Sep 21, 2026, 4:00 PM ET

$5.48

+$0.20 (+3.79%)

Pre-market: Sep 22, 2026, 9:06 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	201.49M	200.45M	193.02M	164.04M	127.95M	92.84M
Cost of Revenue	97.03M	89.35M	83.59M	63.06M	48.81M	41.13M
Gross Profit	104.46M	111.11M	109.43M	100.97M	79.14M	51.71M
Operating Income	-40.38M	-20.52M	-27.85M	-1.8M	9.16M	13.66M
Interest Income	2.22M	10.36M	6.41M	4.62M	49K	110K
Pretax Income	-29.84M	-5.7M	-15.71M	1.26M	5.94M	14.43M
Net Income	-66.54M	-6.02M	-12.15M	2.58M	3M	19.41M
Selling & General & Admin	108.38M	92.23M	93.12M	67.92M	45.55M	24.36M
Research & Development	36.47M	39.4M	44.15M	34.86M	24.44M	13.69M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	144.84M	131.63M	137.27M	102.78M	69.99M	38.05M
Interest Expense	474K	n/a	2.07M	2.57M	1.74M	333K
Selling & Marketing Expenses	49.44M	49.11M	49.15M	33.23M	24.71M	14.99M
Cost & Expenses	241.88M	220.98M	220.86M	165.84M	118.79M	79.18M
Income Tax Expense	36.7M	320K	-3.56M	-1.22M	2.91M	-4.98M
Shares Outstanding (Basic)	127.75M	130.61M	135.28M	134.51M	133.75M	132.99M
Shares Outstanding (Diluted)	127.75M	130.61M	135.28M	138.56M	133.75M	132.99M
EPS (Basic)	-0.52	-0.05	-0.09	0.02	0.03	0.02
EPS (Diluted)	-0.52	-0.05	-0.09	0.02	0.03	0.02
EBITDA	-17.39M	4.79M	-4.41M	9.49M	8.92M	15.37M
EBIT	-29.37M	-5.7M	-13.64M	3.83M	7.68M	14.76M
Depreciation & Amortization	11.98M	10.49M	9.23M	5.66M	1.24M	603K